EAF-16619-63076
2 vaccinations
5 coded responses
13 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 554 / MN
- Registered
- 2021-04-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-16
Dose 1 — Moderna
-
2021-04-13
Dose 2 — Moderna
-
2021-04-15
Registered in v-safe
-
2021-04-15
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness, Taste disorder — Feeling: Fair · Site: Pain, Redness, Swelling · Chills, Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Dizzy; Altered tasteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-16
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetite, Dizziness, Hyperhidrosis, Taste disorder — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: Sweating, dizziness, lack of appetite, altered tasteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness, Nausea, DiarrheaAdult check-in
- 2021-04-19
-
2021-04-20
Survey response — day 7, dose 2MedDRA: Abdominal discomfort — Feeling: GoodFree text: Stomach upsetMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-29
- 2021-05-04
- 2021-05-11
- 2021-05-18
- 2021-05-25
- 2021-07-14
-
2021-10-12
Survey response — 6 months, dose 2MedDRA: Cough, Dysphonia, Fatigue, Nasal congestion, Neck pain, Oropharyngeal pain, Sinus congestion, Sinus headache, Tachycardia, Upper respiratory tract infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I had an upper respiratory infection that started with fatigue and a sore throat, progressed to nasal/sinus congestion, a sever sinus headache and neck pain, tachycardia, and then settled in my voice and ended with a cough.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-13
Survey response — 12 months, dose 2MedDRA: Staphylococcal skin infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Staph infection on my scalp which had to be treated with doxycycline. Diagnosed within 3 weeks of my booster shotMedDRA releases: 2024-11 · check-in free text available
-
2022-04-13
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-04-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-16 | Moderna | |
| 2 | 2021-04-13 | Moderna |
Call center
1 call center case
1 unsuccessful
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Dizzy; Altered taste
Systemic reaction (other): Sweating, dizziness, lack of appetite, altered taste
Release 7 — day 7, dose 2
Systemic reaction (other): Stomach upset
Release 10 — 6 months, dose 2
Symptoms: I had an upper respiratory infection that started with fatigue and a sore throat, progressed to nasal/sinus congestion, a sever sinus headache and neck pain, tachycardia, and then settled in my voice and ended with a cough.
Release 11 — 12 months, dose 2
Symptoms: Staph infection on my scalp which had to be treated with doxycycline. Diagnosed within 3 weeks of my booster shot
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Dysphonia | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Neck pain | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Sinus congestion | · | · | ✓ |
| SD | Sinus headache | · | · | ✓ |
| SD | Staphylococcal skin infection | · | · | ✓ |
| SD | Tachycardia | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | Abdominal discomfort | ✓ | ✓ | ✓ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
| SRO | Taste disorder | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release